Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,477-1,488 of 4,306
Drug study icon
CompletedNCT00419146

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

This summary needs review. Please check the official study record and contact the research team for details.

In Oslo
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 40 Years
Countries
Norway
Sponsor
University Hospital, Aker
Condition
Schizophrenia
Other study type icon
CompletedNCT00749970

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Alicante
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Spain
Sponsor
AstraZeneca
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00430560

Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00440843

Zyprexa and Task Engagement in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
VA Connecticut Healthcare System
Condition
Schizophrenia
Other study type icon
CompletedNCT07673718

α-N-acetylgalactosaminidase in Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Elâzığ
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 65 Years
Countries
Türkiye
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN12055530

Development and preliminary evaluation of a Medication Review Tool for people taking antipsychotic medication

This study is testing a medication approach for people with Conditions treated with antipsychotic medication, including psychosis, schizophrenia, schizoaffective disorder and affective disorder with psychotic symptoms, Mental and Behavioural Disorders, or Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
North East London NHS Foundation Trust (UK)
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2006-006426-26

FAST – A randomised, open-label, parallel, multicentre Phase IIIb Study to evaluate the Efficacy and Safety of Quetiapine IR titrared over 4 Days in Patients with Acute Psychosis (Rapid versus Conv...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sweden
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrug
Countries
Sweden
Sponsor
AstraZeneca AB
Condition
Schizophrenia, Bipolarity
Drug study icon
TerminatedEUCTR 2017-000163-32

The Norwegian Prednisolone in Early Psychosis Study - NorPEPS The role of immune-modulating strategies in the treatment of psychosis

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Norway
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Norway
Sponsor
Helse-Bergen HF
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.